| Long‐term follow‐up of patients with NAFLD and elevated liver enzymes M Ekstedt, LE Franzén, UL Mathiesen, L Thorelius, M Holmqvist, ... Hepatology 44 (4), 865-873, 2006 | 2995 | 2006 |
| Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up M Ekstedt, H Hagström, P Nasr, M Fredrikson, P Stål, S Kechagias, ... Hepatology 61 (5), 1547-1554, 2015 | 2201 | 2015 |
| Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta‐analysis PS Dulai, S Singh, J Patel, M Soni, LJ Prokop, Z Younossi, G Sebastiani, ... Hepatology 65 (5), 1557-1565, 2017 | 1658 | 2017 |
| Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD H Hagström, P Nasr, M Ekstedt, U Hammar, P Stål, R Hultcrantz, ... Journal of hepatology 67 (6), 1265-1273, 2017 | 922 | 2017 |
| Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis G Musso, R Gambino, JH Tabibian, M Ekstedt, S Kechagias, ... PLoS medicine 11 (7), e1001680, 2014 | 708 | 2014 |
| Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study M Ekstedt, LE Franzén, UL Mathiesen, M Holmqvist, G Bodemar, ... Journal of hepatology 47 (1), 135-141, 2007 | 394 | 2007 |
| Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆ QM Anstee, R Darlay, S Cockell, M Meroni, O Govaere, D Tiniakos, ... Journal of hepatology 73 (3), 505-515, 2020 | 349 | 2020 |
| Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: a long‐term follow‐up study H Hagström, P Nasr, M Ekstedt, U Hammar, P Stål, R Hultcrantz, ... Hepatology communications 2 (1), 48-57, 2018 | 255 | 2018 |
| Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease M Ekstedt, LE Franzén, M Holmqvist, P Bendtsen, UL Mathiesen, ... Scandinavian journal of gastroenterology 44 (3), 366-374, 2009 | 237 | 2009 |
| Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis O Govaere, S Cockell, D Tiniakos, R Queen, R Younes, M Vacca, ... Science translational medicine 12 (572), eaba4448, 2020 | 224 | 2020 |
| Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis EA Selvaraj, FE Mózes, ANA Jayaswal, MH Zafarmand, Y Vali, JA Lee, ... Journal of hepatology 75 (4), 770-785, 2021 | 196 | 2021 |
| The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge? JV Lazarus, HE Mark, M Villota-Rivas, A Palayew, P Carrieri, M Colombo, ... Journal of hepatology 76 (4), 771-780, 2022 | 156 | 2022 |
| A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe JV Lazarus, M Ekstedt, G Marchesini, J Mullen, K Novak, JM Pericàs, ... Journal of Hepatology 72 (1), 14-24, 2020 | 154 | 2020 |
| Natural history of nonalcoholic fatty liver disease: a prospective follow‐up study with serial biopsies P Nasr, S Ignatova, S Kechagias, M Ekstedt Hepatology communications 2 (2), 199-210, 2018 | 151 | 2018 |
| Natural history of NAFLD/NASH M Ekstedt, P Nasr, S Kechagias Current hepatology reports 16, 391-397, 2017 | 132 | 2017 |
| Semiquantitative evaluation overestimates the degree of steatosis in liver biopsies: a comparison to stereological point counting LE Franzén, M Ekstedt, S Kechagias, L Bodin Modern pathology 18 (7), 912-916, 2005 | 121 | 2005 |
| Cardiorespiratory fitness, muscular strength, and obesity in adolescence and later chronic disability due to cardiovascular disease: a cohort study of 1 million men H Henriksson, P Henriksson, P Tynelius, M Ekstedt, D Berglind, I Labayen, ... European heart journal 41 (15), 1503-1510, 2020 | 97 | 2020 |
| The European NAFLD Registry: a real-world longitudinal cohort study of nonalcoholic fatty liver disease T Hardy, K Wonders, R Younes, GP Aithal, R Aller, M Allison, P Bedossa, ... Contemporary clinical trials 98, 106175, 2020 | 95 | 2020 |
| Changing epidemiology, global trends and implications for outcomes of NAFLD VWS Wong, M Ekstedt, GLH Wong, H Hagström Journal of hepatology, 2023 | 89 | 2023 |
| Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events J Boursier, H Hagström, M Ekstedt, C Moreau, M Bonacci, S Cure, ... Journal of Hepatology 76 (5), 1013-1020, 2022 | 89 | 2022 |
